Population
Xenopus oocytes expressing wild-type and mutant Kv1.5 potassium channels
Design
Preclinical
Authors
Loading...
Maps Kv1.5 binding residues for S0100176; leaves open whether this advances selective atrial antiarrhythmics in humans.
Identification of key binding residues for the novel Kv1.5 inhibitor S0100176 provides molecular insights for developing targeted therapies for atrial arrhythmias.
Decher et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: